A Single-center, Retrospective Study to Evaluate the Clinical Performance of Artificial Intelligence Medical Assisted Diagnostic Software (VeriSee DR) for Screening of Diabetic Retinopathy in Patients With Diabetes Mellitus
CompletedOBSERVATIONAL
Enrollment
703
Participants
Timeline
Start Date
December 16, 2019
Primary Completion Date
January 31, 2020
Study Completion Date
May 11, 2020
Conditions
Diabetic Retinopathy
Trial Locations (1)
100
National Taiwan University Hospital, Taipei
All Listed Sponsors
collaborator
National Taiwan University Hospital
OTHER
lead
Acer Being Health Inc.
INDUSTRY
NCT04160988 - A Single-center, Retrospective Study to Evaluate the Clinical Performance of Artificial Intelligence Medical Assisted Diagnostic Software (VeriSee DR) for Screening of Diabetic Retinopathy in Patients With Diabetes Mellitus | Biotech Hunter | Biotech Hunter